Opioid Overdose Survivors Face Continued Health Challenges, Higher Death Rate
New York, NY (June 20, 2018)—Survivors of opioid overdose are at great risk of dying in the year after overdose, but the deaths are not always caused by drug use, a new study reveals. In addition to succumbing to drug use, survivors were much more likely to die from respiratory diseases, viral hepatitis, and suicide.
The study, which is the first to evaluate causes of death in opioid overdose survivors, was published online today in JAMA Psychiatry.
“We found that adults who survive an opioid overdose have an exceptionally high risk of dying from a wide range of medical diseases and suicide,” said Mark Olfson, MD, MPH, study leader and Professor of Psychiatry and Epidemiology at Columbia University Vagelos College of Physicians and Surgeons. “While it was not surprising that adults who survive opioid overdoses have high ongoing risks of drug related death and dying from HIV or viral hepatitis, I was taken aback by their markedly elevated risks of dying from so many other conditions including circulatory, respiratory, and digestive system diseases. These findings underscore the overall medical frailty of this patient population and show us that instead of just focusing on survivors’ drug use, we need to coordinate addiction treatment for survivors with general medical and mental health care.”
The researchers analyzed Medicaid records from 45 states to look for causes of death in more than 75,000 adults who were treated for an opioid overdose between 2001 and 2007. More than 5,000 of the adults died within the first year following an overdose—24 times the death rate found in the general population. The most common causes of death were those related to drug use (25 percent), diseases of the circulatory system (13.2 percent), and cancer (10.3 percent). The data show that adults in this population are substantially more likely to die of these causes than adults in the general population.
Compared to the general population, the opioid overdose group was 130 times more likely to die of a drug-use related cause, 40 times more likely to die of chronic respiratory diseases, 30 times more likely to die of viral hepatitis, and 25 times more likely to die of suicide. Women who survived an opioid overdose were nearly 50 times more likely to die of suicide.
“Some of the mortality in this group likely reflects health risk factors that are common in individuals with opioid use disorders, such as cigarette smoking, which can lead to respiratory diseases, cardiovascular, disease, and cancer; and needle sharing, which can lead to hepatitis and HIV,” said Dr. Olfson.
Opioid use has greatly increased in all sectors of society since the data were collected. Dr. Olfson continued, “Given the substantial and diverse mortality risks following opioid overdose, it’s critically important that clinicians coordinate addiction treatment, general medical care, and mental health care in individuals with opioid use disorders.”
The study is titled, “Causes of death following nonfatal opioid overdose.”
The other authors of this paper are Stephen Crystal, PhD (Rutgers University), Melanie Wall, PhD (CUIMC), Shuai Wang, PhD (CUIMC), Shang-Min Liu, MS (CUIMC), Carlos Blanco, MD, PhD (NIDA).
The study was funded by the Agency for Healthcare Research and Quality (U19 HS021112).
The authors report no financial or other conflicts of interest.
Columbia Psychiatry is among the top ranked psychiatry departments in the nation and has contributed greatly to the understanding and treatment of brain disorders. Co-located at the New York State Psychiatric Institute on the NewYork-Presbyterian Hospital/Columbia University Irving Medical Center campus in Washington Heights, the department enjoys a rich and productive collaborative relationship with physicians in various disciplines at the Columbia University Vagelos College of Physicians and Surgeons. Columbia Psychiatry is home to distinguished clinicians and researchers noted for their clinical and research advances in the diagnosis and treatment of depression, suicide, schizophrenia, bipolar and anxiety disorders, eating disorders, substance use disorders, and childhood psychiatric disorders.
Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Irving Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cumc.columbia.edu or columbiadoctors.org.